Medical devices, healthcare technology and the business of care
510(k) clearance · K262153

Pivot Insulin Delivery System

Modular Medical, Inc. · Decision date Sep 2, 2026

MEDTECHLEDGER EXPLANATIONK262153

What did the FDA decide?

The FDA recorded a substantially equivalent (SESE) decision on September 2, 2026 for the Pivot Insulin Delivery System, a Class II infusion pump (21 CFR 880.5725, product code LZG) submitted by Modular Medical, Inc. of San Diego, California, under 510(k) number K262153. The submission was received June 26, 2026 as a Traditional 510(k) reviewed by the Clinical Chemistry panel within the General Hospital specialty; it was not reviewed by a third party and no predetermined change control plan was authorized. SESE denotes 510(k) clearance, not premarket approval.

The filing is a modification of the previously cleared Pivot Insulin Delivery System (K253534), with indications for use stated as unchanged. The listed changes are user-selectable bolus increment settings, updated Controller and Pivot Diabetes App software, minor Controller hardware updates for manufacturability, and related labeling updates. The summary states programmable basal rates of 0.5 to 4.0 units per hour in 0.1-unit increments and a 20-unit maximum individual bolus. The summary does not disclose the specific bolus increment values, detailed test results, or the basis for the predicate's original clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
General Hospital
Decision date
Sep 2, 2026

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K262153
Regulatory pathway
510(k) premarket notification
Product code
LZG
Decision code
SESE
Decision date
Sep 2, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Pump, Infusion, Insulin.

Product code
LZG
FDA device class
2

FDA decision timeline

  1. K262153 received

    Application receipt date recorded by FDA.

  2. K262153 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Modular Medical, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
San Diego, CA

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records